APOE and COVID-19: Variants of ApoE isoforms have been shown to differentially impact SARS‐CoV‐2 cellular infection and COVID‐19 outcome in SARS‐CoV‐2 patients and human iPSC‐based models as well as a mouse model.4, 5, 6